{"ok":true,"trend":{"id":250856,"platform":"news","region":"global","key":"california firm licenses ‘potent’ anti-measles antibodies from vanderbilt health for development, clinical testing","title":"California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing","url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRExNQXR5R0U3QnFuMjB2X1V5QTJLTmdITXExZklwOWtPUjJldDNUMzBJSWxHbnZLWEhJaUdkcWFMODViWGJZQ29fN01SYWpGVEF3aGFSQ2RJT3VwNEdCNEpMbEsyNUcxaXNoRW1FaFFlZ1NPZ2FvUTZnMW1QUmVsVF9vRWVRc0ZZamt3S2FKX0Zoc29pbDZlZ0RzamZocWlrT2trcGZnTGYtTmI4Ukt0TUdsU0dxVlhzNmNSbjJTRnk4TkR6aTAxbzc3VlVlWTcwdEk5WVl2NlRUT3FMN0E?oc=5","first_seen":"2026-09-28T16:03:55.201166Z","last_seen":"2026-09-28T21:31:53.092476Z","last_rank":28,"peak_rank":2,"last_volume":null,"peak_volume":0,"seen_count":5,"score":29.77,"category_hint":"health","section":"health","category":"health","summary":"A California company has licensed potent anti-measles antibodies from Vanderbilt Health to develop them for clinical testing. The agreement moves laboratory research on measles-fighting antibodies toward potential treatments, at a time when measles cases have been resurging in parts of the United States and abroad and health officials are pressing for stronger tools to prevent and treat outbreaks.","why":"Measles outbreaks in the US have renewed attention on new prevention and treatment tools.","tone":"neutral","entities":["Vanderbilt Health","California firm"],"summarized_at":"2026-09-28T22:07:39.550305Z","meta":{"via":"scan","lang":"en","term":"health","source":"news.vumc.org","generic":0.03,"published":"Mon, 28 Sep 2026 15:28:56 GMT"},"nw":0.65,"promo":0.02,"kind":"news_event","importance":1.77,"hidden":false,"hide_reason":null,"judged_at":"2026-09-28T16:04:17.748892Z","title_en":"California firm licenses anti-measles antibodies from Vanderbilt","section_name":"Health","category_name":"Health","timeline":[{"captured_at":"2026-09-28T16:03:55.201166Z","rank":2,"volume":null},{"captured_at":"2026-09-28T17:25:54.379588Z","rank":12,"volume":null},{"captured_at":"2026-09-28T18:47:54.020400Z","rank":8,"volume":null},{"captured_at":"2026-09-28T20:09:53.069038Z","rank":20,"volume":null},{"captured_at":"2026-09-28T21:31:53.092476Z","rank":28,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRExNQXR5R0U3QnFuMjB2X1V5QTJLTmdITXExZklwOWtPUjJldDNUMzBJSWxHbnZLWEhJaUdkcWFMODViWGJZQ29fN01SYWpGVEF3aGFSQ2RJT3VwNEdCNEpMbEsyNUcxaXNoRW1FaFFlZ1NPZ2FvUTZnMW1QUmVsVF9vRWVRc0ZZamt3S2FKX0Zoc29pbDZlZ0RzamZocWlrT2trcGZnTGYtTmI4Ukt0TUdsU0dxVlhzNmNSbjJTRnk4TkR6aTAxbzc3VlVlWTcwdEk5WVl2NlRUT3FMN0E?oc=5","author":"Vanderbilt Health News","title":"California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing","snippet":null,"posted_at":"2026-09-28T15:28:56Z","likes":null}],"elsewhere":[],"window":"7d"}}